Molecular and Biochemical Parasitology
基本情報
Molecular and Biochemical Parasitology provides a medium for rapid publication of investigations of the molecular biology and biochemistry of parasitic protozoa and helminths and their molecular interactions with their definitive and intermediate hosts and their vectors. The main subject areas covered are: the structure, biosynthesis, degradation, properties and function of parasite biomolecules - DNA, RNA, proteins, lipids, carbohydrates and small molecular-weight substances host-parasite relationships particularly as related to specific parasite molecules and to the response of host cells to infection vector-parasite relationships at the molecular level intermediary metabolism and bioenergetics drug target characterization and the mode of action of antiparasitic drugs analysis of gene function, expression, and of genome structure and stability analysis of variation in parasite populations relevant to genetic exchange, pathogenesis, drug and vaccine target characterization, and drug resistance; please note that genetic variation data must be supported by phenotypic/experimental data showing the effect of the variation, and that papers reporting solely on allele frequencies in specific regions will not be accepted. parasite protein trafficking, organelle biogenesis, and cellular structure especially with reference to the roles of specific molecules molecular and biochemical aspects of membrane structure and function parasite programmed cell death, development, and cell division at the molecular level methods reports - descriptions of novel or newly-optimized methods with broad applicability to molecular and biochemical parasitology Papers will only be accepted for publication if they fall within these areas, if they contain original and complete work of high scientific quality, and if they are well presented. Papers solely confirming the conserved functions of genes previously studied in other organisms will not be considered. We welcome short communications documenting a succinct but clear and important advance. 1. Original research articles should report highly significant innovative results not previously published elsewhere. Original articles are limited to 7,000 words per article (all text excluding tables and figure legends). 2. Short Communications need not be formally structured as full papers but should describe significant new findings and observations. The manuscript should ideally contain no more than 4Figures/Tables and 3000 words. The abstract should be limited to 200 words. 3. Methods Reports should contain descriptions of novel or newly-optimised methods with broad applicability to molecular parasitologists. The manuscript should ideally contain no more than 4 Figures/Tables and 3000 words. Results and Discussion are usually combined. The abstract should be limited to 200 words. Methods Reports must include a detailed step-by-step protocol and/or analysis code in the supplementary material. 4. Review articles should cover subjects falling within the scope of the journal which are of active current interest. They may be submitted or invited by the Editors. Review articles should include insightful recommendations for future directions needed for achieving public health impacts. Review articles are limited to 15,000 words per article (all text excluding tables and figure legends). If you have a suggestion for a Review article topic please email Special Content Editor, Geoff Gobert: G.Gobert@qub.ac.uk 5. Perspective articles should include scientifically backed points of view regarding currently relevant, controversial or future-oriented topics pertinent to the scope of MBP. Note that only outlining recent advances in a given field is not acceptable for a Perspective article. Besides stimulating scientific discussion or future research, perspective articles should provide a novel conceptual framework for an old or timely issue. The authors should outline which research directions should be prioritized and highlight specific points explaining why they should be prioritized in future research. Perspective articles are limited to 6,000 words per article (all text excluding tables and figure legends). 6. Letters to the Editor offering comment or useful critique on material published in the journal are welcome. Letters on "hot topics" are also welcome. Note that Letters to the Editors will also be externally reviewed but the decision to publish submitted letters rests with the Editors in Chief. A goal is to publish constructive letters that will permit an exchange of views which will be of benefit to both the journal and its readers. Letters to the Editor are limited to 2,000 words per article (all text excluding tables and figure legends). Most downloaded papers Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services . Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
CiteScore
| 分野 | ランク | パーセンタイル |
|---|---|---|
Immunology and MicrobiologyParasitology |
44 / 79 | 44% |
ジャーナル統計
投稿情報
投稿サイト:
https://www.editorialmanager.com/MOLBIO関連論文
Morphology – composition correlations in carbon nanotubes synthesised with nitrogen and phosphorus containing precursors
Rebecca J. Nicholls, Zabeada Aslam, Michael C. Sarahan, Ana M. Sanchez, Frank Dillon, Antal A. Koós, Nicole Grobert
DOI: 10.1039/C4CP04272G
Water and polymer dynamics in a model polysaccharide hydrogel: the role of hydrophobic/hydrophilic balance
V. Venuti, F. D'Amico, A. Gessini, F. Castiglione, C. Punta, L. Melone, V. Crupi, D. Majolino, F. Trotta, C. Masciovecchio
DOI: 10.1039/C4CP04045G
Schiff base ligands and their transition metal complexes in the mixtures of ionic liquid + organic solvent: a thermodynamic study
Hemayat Shekaari, Amir Kazempour, Maryam Khoshalhan
DOI: 10.1039/C4CP04432K
Electronic structure aspects of the complete O2 transfer reaction between Ni(ii) and Mn(ii) complexes with cyclam ligands
Jhon Zapata-Rivera, Rosa Caballol, Carmen J. Calzado
DOI: 10.1039/C4CP05127K
Using beryllium bonds to change halogen bonds from traditional to chlorine-shared to ion-pair bonds
Ibon Alkorta, José Elguero, Otilia Mó, Manuel Yáñez, Janet E. Del Bene
DOI: 10.1039/C4CP04574B
Intermediates caught in the act: tracing insulin amyloid fibril formation in time by combined optical spectroscopy, light scattering, mass spectrometry and microscopy
A. Gladytz, T. Häupl, K. R. Siefermann
DOI: 10.1039/C4CP03072A
Re-visiting the O/Cu(111) system – when metastable surface oxides could become an issue!
Norina A. Richter, Chang-Eun Kim, Catherine Stampfl, Aloysius Soon
DOI: 10.1039/C4CP04473H
Durability, inactivation and regeneration of silver tetratantalate in photocatalytic H2 evolution
Gang Chen, Jingxue Sun, Chunmei Li, Chade Lv, Yidong Hu
DOI: 10.1039/C4CP04273E
こちらもおすすめ
1-{3-[5-(エチルカルボンイル)-2,4-ジメチル-1H-ピロロール-3-基]プロパニル}ピペリジン-4-カルボン酸について、適用される法規ガイドラインは何ですか?
この化合物はCAS番号1142209-81-1であり、GHS分類では corrosive (腐食性物質) と classified (分類物質) として指定され...
2,2-二氟-1,3-ベンゾジオキサン-5-カルボキシlic酸とは何ですか?
2,2-二氟-1,3-ベンゾジオキサン-5-カルボキシlic酸は、CAS番号656-46-2の化合物で、化学式はC8H4F2O4です。この化合物は白色の結晶性粉...
8-氯-4-色原酮の代替品はありますか?
8-氯-4-色原酮(CAS番号: 49701-11-3)の代替品には、他の色原酮類似物や、構造が似ている化合物があります。例えば、8-メチル-4-色原酮や、他の...
エチル6,6-ジメチル-4,5,6,7-テトラヒドロ-1H-インドアゼー-3-カルボキシレートとは何ですか?
エチル6,6-ジメチル-4,5,6,7-テトラヒドロ-1H-インドアゼー-3-カルボキシレートは、CAS番号1233243-56-5を有する化合物です。これは有...
4-叔丁基-6-氯-嘧啶に適用される法規ガイドラインは何ですか?
4-叔丁基-6-氯-嘧啶はCAS番号3435-24-3で、GHS分類では毒性物質とみなし、GHSの危険性分類が適用されます。REACH規則では登録が必要で、Eu...
維库溴铵杂质Bはどのように合成されますか?
維库溴铵杂质Bは、アンドロステンデンから始まり、一連の合成反応、包括的な選択性と高い収率で合成されます。具体的には、ブロミド化、酸化、ジマーゼ反応、アミド化など...
2-(4-氟苄基)-吡咯烷の物理化学的性質は何ですか?
CAS番号350017-04-8の2-(4-氟苄基)-吡咯烷は、結晶性の白色粉末です。分子量は199.17 g/molで、水に溶けにくいです。化学反応では比較的...
3-喹啉甲醛(2-チロール-8-エチル)は安全ですか?
3-喹啉甲醛(2-チロール-8-エチル)は一定の毒性を持つため、取扱には注意が必要です。使用する際は適切な防護具を着用し、密閉容器で保管・搬送し、直接的な接触を...
エチル3-(ヒドロキシメチル)-1H-ピロール-2-カルボキシレートはどのように保存すればよいですか?
エチル3-(ヒドロキシメチル)-1H-ピロール-2-カルボキシレートは、室温(25℃)以下で保存し、直射日光を避け、乾燥した環境で保管することが推奨されます。ま...















![2-{3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl}[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride (1:1) structure 2-{3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl}[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride (1:1) structure](https://static.chemtradehub.com/structs/253/25332-39-2-496e.webp)

